Popular Education
2023 Revision to USP 797: What Home Infusion Pharmacies Need to Know
On Novemeber 1, 2022 USP released the revised version of General Chapter Pharmaceutical Compounding--Sterile Preparations, which becomes enforceable November 1, 2023.
Progress with Payors: From Commercial to Medicare + Recent Regulatory Updates
Join Connie Sullivan, President and CEO of the National Home Infusion Association as she describes the driving forces behind the latest industry trends and discusses events that will impact infusion providers over the next five years.
Treatment of Neurological Disorders with Immunoglobulin Therapy
This program will review the current immunglobulin therapies that are FDA approved for both autoimmune and neurological disorders. 1 CE
